Fattaey Ali Ph.D.

Avg. Two Year Performance

(20%) Avg. Purchase Return

(9%) Compound

No sale track record

	1 Mo	3 Mo	6 Mo	1 Yr	2 Yr
Average Purchase Return	(16%)	(22%)	45%	9%	(20%)
Purchase Success Rate	1 of 3	1 of 3	1 of 3	1 of 3	2 of 3
Average Sale Return	--	--	--	--	--
Sale Success Rate	--	--	--	--	--

Curis Inc.

Drugs » Biotechnology

President & CEO, Director:

Holdings: 322.14K shares

Sentiment

Avg. Two Year Performance

No purchase track record

No sale track record

Last Three Months:

0 Net Amount

Buy:	0	--
Sell:	0	--